% | $
Quotes you view appear here for quick access.

Affymax, Inc. Message Board

  • alliamon1099 alliamon1099 Feb 14, 2013 11:27 AM Flag

    strong buy

    ffymax weakness a buying opportunity, says Piper Jaffray
    Piper Jaffray said it remains confident in Affymax's supply agreement with Fresenius Medical after Fresenius paused the expansion of its Omontys pilot. Piper believes the pause is part of Fresenius's decision making process and notes that patients who are on Omontys are able to remain on the drug, which it views as a a positive sign. The firm recommends buying shares of Affymax on today's weakness.

    Sentiment: Strong Buy

0.0610.0000(0.00%)10:53 AMEDT